(Q42675463)

English

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial

scientific article published on May 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 November 2017

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial (English)

1 reference

Europe PubMed Central

4 November 2017

multicenter clinical trial

0 references

author name string

Ronald L Fellman

1

1 reference

Europe PubMed Central

4 November 2017

E Kenneth Sullivan

2

1 reference

Europe PubMed Central

4 November 2017

Marla Ratliff

3

1 reference

Europe PubMed Central

4 November 2017

Lewis H Silver

4

1 reference

Europe PubMed Central

4 November 2017

Jess T Whitson

5

1 reference

Europe PubMed Central

4 November 2017

F Darell Turner

6

1 reference

Europe PubMed Central

4 November 2017

Alan L Weiner

7

1 reference

Europe PubMed Central

4 November 2017

Alberta A Davis

8

1 reference

Europe PubMed Central

4 November 2017

Travoprost Study Group

9

1 reference

Europe PubMed Central

4 November 2017

publication date

1 May 2002

1 reference

Europe PubMed Central

4 November 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

4 November 2017

109

1 reference

Europe PubMed Central

4 November 2017

5

1 reference

Europe PubMed Central

4 November 2017

998-1008

1 reference

Europe PubMed Central

4 November 2017

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular effects of topical beta-blockers during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular responses to metipranolol and timolol eyedrops in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

[Changes in lung function following administration of eyedrops containing timolol, metipranolol, pindolol and pilocarpine in healthy probands and patients with mild bronchial asthma].

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Topical Betaxolol, Timolol, and Placebo on Pulmonary Function in Asthmatic Bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Anterior uveitis associated with latanoprost

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost-associated cystoid macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

[3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901010-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(02)01010-2

1 reference

Europe PubMed Central

4 November 2017

1 reference

Europe PubMed Central

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42675463&oldid=1965215443"